Key Insights

Highlights

Success Rate

89% trial completion (above average)

Published Results

22 trials with published results (7%)

Research Maturity

159 completed trials (52% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

6.5%

20 terminated out of 306 trials

Success Rate

88.8%

+2.2% vs benchmark

Late-Stage Pipeline

9%

28 trials in Phase 3/4

Results Transparency

14%

22 of 159 completed with results

Key Signals

22 with results89% success20 terminated

Data Visualizations

Phase Distribution

230Total
Not Applicable (156)
Early P 1 (5)
P 1 (21)
P 2 (20)
P 3 (14)
P 4 (14)

Trial Status

Completed159
Unknown61
Recruiting32
Terminated20
Active Not Recruiting15
Not Yet Recruiting9

Trial Success Rate

88.8%

Benchmark: 86.6%

Based on 159 completed trials

Clinical Trials (306)

Showing 20 of 20 trials
NCT06724276Not ApplicableCompleted

Combined Treatment for Non-Healing Wounds in Chronic Lower Extremity Arterial Disease: A Comparative Study

NCT07840300Not ApplicableNot Yet RecruitingPrimary

Activity Reduction vs Advice for Plantar Hotspots in Diabetes

NCT07841730Not ApplicableNot Yet RecruitingPrimary

Tibial Nerve Mobilization Versus Multisensory Exercises in Patients With Diabetic Foot Ulcer

NCT06826339Phase 4Recruiting

Evaluating Several Cellular, Acellular, and Matrix-like Products (CAMPs) and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot and Venous Leg Ulcers.

NCT06104969Recruiting

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

NCT06092827Not ApplicableCompletedPrimary

Feasibility and Acceptability of Non Weight-bearing Physical Activity for People With Diabetic Foot Ulceration

NCT07690566Not ApplicableCompletedPrimary

Ultrasonic Enhancement Delivery of Phosphodiesterase Inhibitors Nanoparticles for Diabetic Management of the Foot

NCT07632001Not ApplicableRecruiting

Miro3D Wound Matrix for Treatment of Diabetic Foot Ulcers

NCT06565156Not ApplicableCompleted

Non-healing Diabetic Foot Ulcers Treated With Standard Care With or Without BR-AM

NCT05728411Not ApplicableActive Not RecruitingPrimary

Effectiveness of Remote Foot Temperature Monitoring

NCT05950659Not ApplicableRecruiting

WIREDUP: Wearable Insoles for Recurrent Diabetic Ulcer Prevention

NCT05579743Not ApplicableCompletedPrimary

Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers

NCT05380544Not ApplicableActive Not RecruitingPrimary

Extracorporeal Shockwave Therapy for Diabetic Foot Ulcers

NCT07641764Not ApplicableActive Not RecruitingPrimary

3D Printed vs Ready-to-Wear Insoles for Diabetic Neuropathy

NCT02264288Phase 2Terminated

Efficacy and Safety of Intramuscular PDA-002 in Subjects With Diabetic Foot Ulcer With and Without PAD.

NCT02378493Not ApplicableCompletedPrimary

Evaluation of the Antibiofilmogramme® Test During Diabetic Foot Infections

NCT07563751Not ApplicableNot Yet RecruitingPrimary

Effectiveness of a Structured Educational Program on Pain Intensity, Self-Efficacy, Foot Self-Care Behaviors, and Health-Related Quality of Life Among Adults With Diabetic Foot

NCT04981067Not ApplicableActive Not RecruitingPrimary

Dose-finding Study: Popliteal Sciatic Nerve Block in Patients Undergoing Diabetic Foot Surgery

NCT02460081Phase 2WithdrawnPrimary

Hemodynamic Effects of Intramuscular PDA-002 in Subjects Who Have Diabetic Foot Ulcer With Peripheral Arterial Disease

NCT07553468Not ApplicableCompletedPrimary

Stromal Vascular Cells for the Treatment of Diabetic Peripheral Neuropathy

Scroll to load more

Research Network

Activity Timeline